Novo Nordisk Wegovy’s NHS access marks milestone in obesity treatment, but challenges remain:… EP News Bureau Oct 3, 2023 The constrained supply of Wegovy and the necessity of ongoing obesity management support are key considerations
Eli Lilly’s Mounjaro to become leading GLP-1 therapy for type 2 diabetes in NHS in UK: GlobalData EP News Bureau Sep 21, 2023 The National Institute for Health and Care Excellence (NICE) provided guidance in August 2023 explaining that where triple therapy…
